Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

ALSA Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 5
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Genetics
  • Product Research

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
819 Capital California, San Francisco, United States
Berwind Private Equity Harvard, Massachusetts, United States
Closed Loop Ventures New City, New York, United States
Ericsson Ventures California, Santa Clara, United States
Holtzbrinck Digital Bayern, Germany, München
Hongrui Touzi China, Jiading, Shanghai
Insight Capital Beijing, Beijing, China
KPIT Technologies India, Maharashtra, Pune
Life.SREDA Central, Central Region, Singapore
Maker Institute CAS China, Guangdong, Tianjin
MCM Capital Partners Beachwood, Ohio, United States
Merian Global Investors England, London, United Kingdom
Nanoholdings -
Nobori -
Platinum-Montaur Life Sciences New York, New York, United States
PPL Allentown, Pennsylvania, United States
Renovus Capital Partners Pennsylvania, United States, Wynnewood
Seashell Capital Beijing, Beijing, China
Vicente Capital Partners California, Los Angeles, United States
XN New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Vantage Biosciences

Biotechnology
Health Care
Product Research
Therapeutics
19 Jul 2023 London, England, United Kingdom

Jatri

Apps
Information Technology
Internet
Public Transportation
Reservations
Ticketing
Transportation
$5M15 Apr 2023 Dhaka, Dhaka Division, Bangladesh

IGEM Therapeutics

Biotechnology
Genetics
Therapeutics
$42M02 Mar 2022 London, England, United Kingdom

Promatix

Biotechnology
Pharmaceutical
Therapeutics
08 Mar 2021 London, England, United Kingdom

Montis Biosciences

Biotechnology
Therapeutics
$9M20 Feb 2020 Belgium, Flemish Brabant, Belgium

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent ALSA Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 9M
Peak activity year 2023
Lead investments 0
Follow on index 0.17
Group Appearance index 0.50

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Vantage Biosciences

Biotechnology
Health Care
Product Research
Therapeutics
19 Jul 2023 London, England, United Kingdom

Jatri

Apps
Information Technology
Internet
Public Transportation
Reservations
Ticketing
Transportation
$5M15 Apr 2023 Dhaka, Dhaka Division, Bangladesh

IGEM Therapeutics

Biotechnology
Genetics
Therapeutics
$42M02 Mar 2022 London, England, United Kingdom

Promatix

Biotechnology
Pharmaceutical
Therapeutics
08 Mar 2021 London, England, United Kingdom

Montis Biosciences

Biotechnology
Therapeutics
$9M20 Feb 2020 Belgium, Flemish Brabant, Belgium
Crunchbase icon

Content report

The following text will be sent to our editors: